Nedira Salzman-Frenkel.
Corporate Officer/Principal chez NEUROSENSE THERAPEUTICS LTD.
Profil
Nedira Salzman-Frenkel is currently the Vice President-Business Development at Neurosense Therapeutics Ltd.
Previously, she served as the Chief Executive Officer at Radikal Therapeutics, Inc. from 2017 to 2021.
Ms. Salzman-Frenkel holds a graduate degree from The Hebrew University of Jerusalem, an undergraduate degree from Ben-Gurion University of the Negev, and an MBA from Recanati School of Business Administration.
Postes actifs de Nedira Salzman-Frenkel.
| Sociétés | Poste | Début |
|---|---|---|
| NEUROSENSE THERAPEUTICS LTD. | Corporate Officer/Principal | 01/03/2022 |
Anciens postes connus de Nedira Salzman-Frenkel.
| Sociétés | Poste | Fin |
|---|---|---|
Radikal Therapeutics, Inc.
 Radikal Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Radikal Therapeutics, Inc. develops transformative pharmaceuticals of bifunctional edox-based small molecules. The company was founded by Andrew L. Salzman and is headquartered in West Tisbury, MA. | Directeur Général | 01/10/2021 |
Formation de Nedira Salzman-Frenkel.
| The Hebrew University of Jerusalem | Graduate Degree |
| Ben-Gurion University of the Negev | Undergraduate Degree |
| Recanati School of Business Administration | Masters Business Admin |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| NEUROSENSE THERAPEUTICS LTD. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Radikal Therapeutics, Inc.
Radikal Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Radikal Therapeutics, Inc. develops transformative pharmaceuticals of bifunctional edox-based small molecules. The company was founded by Andrew L. Salzman and is headquartered in West Tisbury, MA. | Commercial Services |